INTRODUCTION
============

Bacterial small RNAs (sRNAs) play major roles in the physiology of the cell. Not fully recognized until the last decade, now about 100 of these molecules have been identified in the *Escherichia coli* genome ([@B1]), which represents more than 2% of the total number of genes. These sRNAs are usually between 50 and 400 nt in length and in most cases do not encode any protein. In general, their synthesis is tightly regulated and, as a result, they are expressed under highly specific conditions. Once synthesized, sRNAs either positively or negatively regulate the expression of one or several target genes. Several major stress regulons have been shown to include at least one sRNA involved in the cellular stress response ([@B2]).

Bacterial sRNAs do not all follow the same mode of action; the most extensively studied group is the class of Hfq-binding sRNAs, comprising at least one-third of the experimentally verified *E. coli* sRNAs ([@B3]). These sRNAs usually base-pair with their target-mRNAs and regulate the translation and/or stability of the mRNA at the post-transcriptional level. In most cases, this regulation is negative and sRNAs inhibit ribosome binding by base-pairing in the vicinity of the target ribosome-binding site. Nevertheless, several examples of positive control by sRNAs have been reported that are generally based on the same mechanism: the pairing of the activator sRNA to its target mRNA inhibits the formation of an inhibitory secondary structure and thereby derepresses translation of the target gene ([@B4; @B5; @B6]).

Hfq is an RNA chaperone that was first identified for its role in the replication of the RNA phage Qβ, but now appears to have multiple roles for cellular RNAs ([@B7]). It was shown to stabilize several Hfq-binding sRNAs *in vivo* ([@B8]) and to enhance base-pairing between sRNA and target-mRNA *in vitro* ([@B8; @B9; @B10; @B11]); besides affecting sRNA accumulation, Hfq is also likely required for sRNA action *in vivo* ([@B12]), at least in Gram-negative bacteria. In addition, Morita *et al.* ([@B13]) showed that Hfq copurified with Hfq-binding sRNAs, such as SgrS or RyhB, and with the RNase E endonuclease. Hfq could therefore recruit a ribonucleic complex, which would account for the observed RNase E-dependent destabilization of a target-mRNA after its pairing with a regulatory sRNA (as in reference 14 for instance).

As the role of many sRNAs has started to be investigated, it appears that at least eight of these molecules, and probably more, downregulate the synthesis of outer membrane proteins (OMP) in *E. coli* and other enterobacteria ([@B15; @B16; @B17; @B18; @B19]). Two of these, OmrA and OmrB, are sRNAs encoded by adjacent genes on the *E. coli* chromosome. They are almost identical at their 5′ and 3′ ends, but have a distinct central region. We have previously shown that both OmrA and OmrB are made in response to the activation of the EnvZ-OmpR two-component system and that their production results in a decrease in the level of several OMPs, such as the OmpT protease and the CirA, FecA and FepA receptors for iron--siderophore complexes ([@B20]).

This study focuses on the mechanism by which OmrA/B sRNAs downregulate their targets. Our results show that a conserved short region at the 5′ end of OmrA/B directly base-pairs with *ompT* and *cirA* mRNAs in the translation initiation region (TIR). Interestingly, this 5′ end of OmrA/B is also involved in the regulation of their other targets, including the newly identified *ompR* target. Since OmpR activates the transcription of *omrA* and *omrB*, these sRNAs should limit their own synthesis by directly downregulating their activator.

MATERIAL AND METHODS
====================

Bacterial strains
-----------------

Strains used in this study are listed in [Table 1](#T1){ref-type="table"}. Unless otherwise indicated, cells were grown aerobically in LB medium at 37°C. When necessary, antibiotics were used at the following concentrations: 50 μg/ml ampicillin on plates or 150 μg/ml in liquid cultures, 25 μg/ml kanamycin and 10 or 25 μg/ml chloramphenicol. Mutant alleles of the *rne* gene ([@B14]) as well as *Δfur::cm* ([@B20]), *Δfur::kan* ([@B21]), *ΔomrAB::kan* ([@B20]) and *hfq::cm* ([@B22]) were introduced by P1 transduction. For cloning procedures, PCR amplification was carried out using the Expand High Fidelity PCR system (Roche) and DH5α was used as the recipient strain. Table 1.Strains used in this studySrainDescriptionConstruction or sourceMG1655Wild-type strainF. BlattnerDJ480MG1655 *Δlac*X174D. JinDJ624DJ480 *mal::lacI^q^*D. JinMG1099DJ624 *ΔomrAB::kan*([@B20])MG1100MG1099 *Δfur::cm*([@B20])MG1188MG1099 λRS*ompT-lacZ*This studyMG1189MG1100 λRS*cirA-lacZ*This studyMG1193DJ624 *Δfur::kan* λRScirA-lacZThis studyMG1195MG1193 *hfq::cm*This studyMG1204MG1099 λRS*ompTmut2-lacZ*This studyMG1205MG1100 λRS*cirAΔ2-lacZ*This studyMG1206MG1100 λRS*cirAΔ1-lacZ*This studyMG1253MG1100 λRS*cirAmutI-lacZ*This studyMG1254MG1100 λRS*cirAup-lacZ*This studyMG1255MG1100 λRS*cirAmutIIa-lacZ*This studyMG1256MG1100 λRS*cirAmutIIb-lacZ*This studyMG1261MG1100 λRS*cirAmutI + IIa-lacZ*This studyMG1272MG1100 *rnc-14::Tn10*MG1100 + P1 (EM1321), ([@B14])MG1273MG1100 *zce-726::Tn10*MG1100 + P1 (EM1279), ([@B14])MG1274MG1100 *rne-3071 zce-726::Tn10*MG1100 + P1 (EM1277), ([@B14])MG1277MG1100 *rne-131 zce-726::Tn10*MG1100 + P1 (EM1377), ([@B14])MG1279MG1099 *hfq::cm*This studyMG1281MG1099 *ompTmut2*This studyMG1307MG1099 *ompT-Flag*This studyMG1309MG1099 *ompTmut2-Flag*This studyMG1340MG1100 λRS*cirAup/2-lacZ*This studyMG1341MG1100 λRS*cirAup/3-lacZ*This studyMG1398MG1655 *ΔomrAB::kan mal::lacI^q^ ΔaraBAD araC^+^* pBAD-*ompR-lacZ*This studyMG1403MG1655 *ΔomrAB::kan mal::lacI^q^ ΔaraBAD araC^+^* pBAD-*ompRmut2-lacZ*This study

Strains carrying *ompT-lacZ* or *cirA-lacZ* translational fusions were constructed as follows. DNA fragments corresponding to nts --220 to +30 of either *ompT* or *cirA* followed by a Flag tag (sequence 5′-GACTACAAGGACGACGATGACAAA-3′) were cloned in frame with *lacZ* between the EcoRI and BamHI sites (for *ompT*) or between the EcoRI and SmaI sites (for *cirA*) of the pRS414 plasmid ([@B23]) to give plasmids pRSompT10 or pRScirA10, respectively. These plasmids were then crossed with λRS468 bacteriophage and monolysogens were constructed as previously described ([@B23]). Mutations in these translational fusions were introduced in the pRSompT10 or pRScirA10 plasmid using the Quick-change II XL site-directed mutagenesis kit (Stratagene) and mutant monolysogens were then made as above.

Strains carrying variants of the *ompT* chromosomal copy (strains MG1281, MG1307 and MG1309) derive from a strain where a *cat-sacB* cassette was recombined in the *ompT* gene as previously described. An oligonucleotide carrying the Flag tag sequence or PCR products of a fragment of *ompT* DNA with the mut2 change either by itself or in combination with the Flag tag were then used to replace the cassette by selecting recombinants able to grow on sucrose plates. Candidates were checked for chloramphenicol sensitivity and the full *ompT* gene was sequenced. The *mal::lacI^q^* allele was then introduced in two steps. First, a *crp::cat* mutation was P1 transduced into these strains. Then, after P1 transduction of *mal::lacI^q^*, candidates were selected as clones that grew on minimal medium + 0.2% sorbitol, but not on minimal medium + 0.2% maltose.

Finally, the strain carrying a pBAD-*ompR-lacZ* fusion (or pBAD-*ompRmut2-lacZ*) was made by replacing the *cat-sacB* cassette of a pBAD-*cat-sacB* construct that was inserted upstream of *lacZ* gene in strain PM1205 (from P. Mandin, unpublished) by a DNA fragment carrying nts --123 to +30 of *ompR* (or *ompRmut2*).

Plasmids
--------

Plasmids pBRplacOmrA, pBRplacOmrB, pBAD-OmrA and pBAD-OmrB have been described previously ([@B20]). mut2\* and mut3\* derivatives of pBRplacOmrA and pBRplacOmrB plasmids were made using the Quick-change II XL mutagenesis kit (Stratagene). After sequencing, the AatII-EcoRI fragment was subcloned into pBRplac to get rid of unwanted secondary mutations.

RNA extraction and northern blot analysis
-----------------------------------------

RNA was extracted from cells in exponential phase as previously described ([@B20]). Typically, cells were grown in LB + ampicillin to an OD~600~ of about 0.3, and synthesis of OmrA/B was induced using 100 μM IPTG ([Figures 1](#F1){ref-type="fig"}A and B, [3](#F3){ref-type="fig"}B, [6](#F6){ref-type="fig"}C and [7](#F7){ref-type="fig"}B) or 0.2% arabinose ([Figure 1](#F1){ref-type="fig"}C). RNA was harvested at the indicated time-points. For [Figure 5](#F5){ref-type="fig"}, RNA was extracted from strain MG1189 transformed with different plasmids and grown in LB medium supplemented with ampicillin and 100 μM IPTG at the same time that samples were taken to assay the β-galactosidase activity, i.e. at an OD~600~ of about 0.4. After extraction, RNA was ethanol-precipitated, resuspended in DEPC-water and its concentration was estimated by measuring the OD at 260 nm. Figure 1.Degradation of *ompT* and *cirA* mRNA after OmrA/B induction is dependent on the RNAse E endonuclease, but not on RNAse III. RNA levels of OmrA/B as well as of *ompT* and *cirA* mRNA were followed by northern blot analysis at 0, 4 and 10 min after induction of OmrA/B. This was done in RNase E (**A** and **B**) or RNase III (**C**) mutant cells as well as in their wild-type counterparts. Blots were also probed for SsrA or *ompA* mRNA as loading controls. This experiment was carried out using strains MG1273 (*rne^+^*), MG1274 (*rne-3071*), MG1277 (*rne-131*), MG1100 (*rnc^+^*) and MG1272 (*rnc^−^*).

Northern analysis was then performed as follows. When the level of OmrA, OmrB or SsrA was analyzed, 3 μg total RNA were separated on a 5 or 10% acrylamide TBE-urea gel (Biorad) and then transferred onto a nylon membrane as previously described ([@B20]). To analyze the level of other RNAs, a constant amount of total RNA (between 6.5 and 15 μg) was separated onto a 1% agarose gel in MOPS buffer and transferred to a nylon membrane by capillary action. Detection was carried out using biotinylated probes and the Brightstar Biodetect kit (Ambion). SsrA and ompA RNAs were used as negative controls. Sequences of probes specific to OmrA, OmrB, SsrA, *ompT*, *cirA*, *fecA*, *fepA* or *ompA* were previously published ([@B20]). The sequence of the *ompR*-probe is ^5′^Biotin-cacgagtcagcaggcgatccatctgttctgcattagcgacgc^3′^. In [Figures 5--7](#F5 F6 F7){ref-type="fig"}, wt and mutant OmrA or OmrB were detected with OmrAmut-probe (^5′^Biotin-caggttggtgcaagagacagggtacgaagagcgtaccg^3′^) or OmrBmut-probe (^5′^Biotin-cgcaggctggtgtaattcatgtgctcaacccgaagttga^3′^), respectively. When needed, membranes were stripped by boiling in SDS 0.5% for 10 min and could then be hybridized with another probe. Up to three different probes were used per membrane.

β-Galactosidase assays
----------------------

Cells were grown in LB medium supplemented with ampicillin and 100 μM IPTG. Duplicate samples of 0.5 ml were removed in exponential phase (OD~600~ about 0.4), mixed with 0.5 ml of cold Z-buffer and their β-galactosidase activity was assayed as described ([@B24]). Results are the average of at least two independent experiments.

Western blot analysis
---------------------

Cells were grown in LB medium containing ampicillin and IPTG at a final concentration of 100 μM. When the OD~600~ reached 0.4, proteins were precipitated with 5% TCA. The pellet was then washed with 80% acetone and resuspended in SDS-sample buffer (New England Biolabs), so that the concentration would correspond to 15 OD~600~/ml. For detection of the OmpT-Flag protein, 10 μl of these samples were then subject to electrophoresis on 10% Bis--Tris NuPAGE Gel (Invitrogen) in MOPS buffer, transferred to a nitrocellulose membrane and flagged proteins were detected using the anti-Flag M2 monoclonal antibody-alkaline phosphatase conjugate (Sigma) following manufacturer\'s instructions, combined with the Lumi-Phos chemiluminescent substrate (Pierce). For the detection of EFTu, 7.5 μl of samples diluted 100-fold were separated and transferred as above, and then probed using a 1:3000 dilution of anti-EFTu antiserum and the ECL detection kit (Amersham).

RESULTS
=======

Degradation of *ompT* and *cirA* mRNAs in response to OmrA/B production requires the RNase E endonuclease
---------------------------------------------------------------------------------------------------------

Since several targets of Hfq-binding sRNAs have been shown to be degraded by RNase E ([@B14],[@B25],[@B26]), this essential endonuclease was a good candidate for degrading OmrA/B targets. This was tested by looking at the effect of two different mutations of the enzyme on *ompT* and *cirA* mRNA levels after induction of OmrA or OmrB expression ([Figure 1](#F1){ref-type="fig"}). The first mutant, *rne-3071*, is a thermosensitive allele carrying a single amino acid change in the N-terminal domain of the protein that affects the catalytic activity of the protein; the protein becomes inactive at elevated temperature and the strain is unable to grow ([@B27]). The second mutant, *rne-131*, carries a two nucleotide deletion resulting in a frameshift and the appearance of a premature stop codon ([@B28]). The resulting truncated protein lacks the domain involved in the interaction with other components of the degradosome; the C-terminal domain is not essential and the strain carrying this truncation can be grown at most temperatures ([@B29]).

Cells carrying either *rne* mutation and ectopically expressing OmrA or OmrB from an IPTG-inducible promoter were grown to exponential phase (OD~600~ \> 0.3), transferred to nonpermissive temperature to inactivate the RNase E if needed (for the *rne-3071* mutant, panel A) and the level of *ompT* and *cirA* mRNAs was followed by northern blot after induction of OmrA/B expression. In wild-type (wt) cells, at both 37°C and 43.5°C, degradation of *ompT* mRNA is visible as soon as 4 min after the induction of OmrA/B expression and most of the *ompT* message is gone by 10 min ([Figure 1](#F1){ref-type="fig"}, top of panels A and B). Similar results were obtained with *cirA* mRNA; it was no longer detectable after 4 min of OmrA/B induction, while the control mRNA for *ompA* was unaffected. In the *rne-3071* mutant, both *ompT* and *cirA* mRNAs were stabilized; no degradation was observed during the 10 min that followed induction ([Figure 1](#F1){ref-type="fig"}A, bottom panel). RNase E endonucleolytic activity is therefore required for the degradation of at least these two target mRNAs of OmrA/B. Degradation of these targets was also decreased in the *rne-131* mutant ([Figure 1](#F1){ref-type="fig"}B), suggesting that the degradosome may play a role as well. In these experiments, accumulation of OmrA/B was unaffected by *rne*-3071 or *rne*-131 alleles and control of both *ompT* and *cirA* by these sRNAs was similar at 37°C and 43.5°C.

The requirement for endoribonuclease RNase III, that belongs to the same family as the eukaryotic Dicer endonuclease ([@B30]), was investigated as well, using a null allele of the *rnc* gene, encoding RNase III. Because we found that in the *rnc^−^* strain used (strain MG1272), both OmrA and OmrB were strongly expressed from pBRplac derivatives, even without induction (data not shown), the OmrA/B RNAs were ectopically expressed from a P~BAD~ promoter using arabinose in this set of experiments ([Figure 1](#F1){ref-type="fig"}C). Under these conditions, the decrease in *ompT* mRNA is not as striking as with expression from a P~lac~ promoter, although the decrease in *cirA* is complete (compare [Figure 1](#F1){ref-type="fig"}B and C, top panels). The decrease in *ompT* and *cirA* mRNA levels after OmrA/B induction is at least as marked in both *rnc^+^* and *rnc^−^* cells ([Figure 1](#F1){ref-type="fig"}C), showing that RNase III is not required in the degradation of these targets of OmrA/B.

These results are consistent with findings for other Hfq-dependent sRNAs in *E. coli*, in which RNase E but not RNase III was found to be primarily responsible for mRNA degradation (reference 14 for instance).

Repression of *ompT* or *cirA* translational fusions by OmrA/B differs greatly in extent
----------------------------------------------------------------------------------------

For many Hfq-dependent sRNAs, pairing with negatively regulated mRNAs overlaps or is near the RBS and translation initiation codon. Initial pairing predictions for OmrA and B and these regions yielded a short possible pairing for OmrA/B and *cirA*, overlapping the RBS ([Figure 2](#F2){ref-type="fig"}B). Nucleotides 2 to 24 of OmrA or OmrB, most of which are conserved between these two sRNAs ([Figure 2](#F2){ref-type="fig"}A), are predicted to be involved in this interaction, in two stretches, one of 8 nt and the other of 12 nt. They would imperfectly base-pair with the nucleotides --35 to --10 of *cirA* mRNA, i.e. in the vicinity of the *cirA* TIR, which suggests that OmrA/B could inhibit ribosome binding to *cirA* message. For *ompT*, the longest stretch of predicted pairing is downstream from the start codon, at nt 12--20 of the translated region ([Figure 2](#F2){ref-type="fig"}C); once again, this pairing is with the 5′ end of OmrA and OmrB. Figure 2.Predicted base-pairing between OmrA/B and *ompT* or *cirA* mRNA. (**A**) Sequences of *E. coli* OmrA and OmrB sRNAs. (**B**) Prediction of pairing with *cirA* mRNA. (**C**) Prediction of pairing with *ompT* mRNA. Nucleotides in red are conserved between OmrA and OmrB. Start codons and putative Shine--Dalgarno sequences are in gray.

In order to examine whether these regions of the targets were necessary and sufficient for OmrA/B action, we constructed translational fusions between either *ompT* or *cirA*, and the *lacZ* reporter gene. Both CirA and OmpT are outer membrane proteins; in order to use β-galactosidase fusions to measure their expression, we designed fusions that should not be exported from the cytoplasm. More precisely, the DNA region from 220 nt upstream of the ATG start codon and 30 nt downstream (i.e. encoding 10 amino acids, which is only part of the signal sequence) was fused in frame with an eight-amino-acid FLAG tag and the *lacZ* gene. These constructs were then introduced in single copy at the lambda attachment site of a *Δlac* strain.

The effect of OmrA/B long-term expression on the expression of these fusions was then assayed by measuring the β-galactosidase activity associated with either fusion after transformation with a plasmid overexpressing either sRNA. Because *cirA* expression is Fur-repressed at the transcriptional level, activity of the *cirA-lacZ* fusion was measured in a *Δfur::cm* background.

As shown in [Figure 3](#F3){ref-type="fig"}A and Table S1, OmrA and OmrB reduced the activity of *cirA-lacZ* 10.6- and 5.5-fold, respectively under these conditions. Both OmrA and OmrB bind tightly to Hfq ([@B31],[@B32]), and therefore were expected to depend on Hfq for function. The requirement for Hfq for control by OmrA/B was assayed on *cirA-lacZ* expression. In an *hfq* mutant strain, control of *cirA-lacZ* by OmrA/B was fully abolished ([Figure 3](#F3){ref-type="fig"}A). This result confirms that the *cirA-lacZ* fusion mimics the major expectations for OmrA and OmrB regulation of *cirA*, i.e. strong negative regulation and dependence upon Hfq. Therefore, it seems likely that the fusion contains the necessary elements for Omr regulation. Figure 3.OmrA and OmrB control *ompT* and *cirA* expression in an Hfq-dependent manner. (**A**) Specific β-galactosidase activity of the *cirA-lacZ* or *ompT-lacZ* fusion strains transformed with an OmrA- or OmrB-overexpressing plasmid or the corresponding control vector. Strains used in this experiment are MG1193, MG1195 and MG1188. (**B**) Northern blot analysis of *ompT* mRNA levels after OmrA/B induction in an *hfq^+^* (strain MG1099) or *hfq^−^* (strain MG1279) background. SsrA and *ompA* RNAs were used as loading controls. When probed together, the relative levels of Omr sRNAs in *hfq^+^* and *hfq^−^* cells were similar to the ones shown in (B) (data not shown).

In contrast, the effect of OmrA/B on the expression of *ompT*-*lacZ* was extremely weak ([Figure 3](#F3){ref-type="fig"}A and Table S1). This result suggested that elements within the *ompT* transcript that are important for the full regulation by OmrA and OmrB are not present in this fusion, and therefore the regulation of *ompT* may differ somewhat from that of *cirA*. Because of this modest effect of OmrA/B on the translational fusion, the requirement for Hfq was analyzed by a direct examination of the levels of *ompT* mRNA after OmrA/B induction in an *hfq* mutant ([Figure 3](#F3){ref-type="fig"}B). In contrast to a wt strain, no degradation of *ompT* mRNA was visible in this mutant for as long as 10 min after induction, clearly showing that control of *ompT* by OmrA/B is Hfq-dependent as well.

In the absence of Hfq, both OmrA and OmrB fail to accumulate as much as in wt cells ([Figure 3](#F3){ref-type="fig"}B), which explains, at least in part, the need for Hfq in the control of their targets. Lower levels of Hfq-dependent RNAs are commonly seen in *hfq* mutants, due to rapid turnover of these sRNAs ([@B14]). However, *in vitro* experiments clearly demonstrate direct roles for Hfq in pairing of sRNAs and their targets ([@B33]). It seems likely that Hfq is important in both capacities for OmrA and OmrB *in vivo* action.

Role of the 5′ leader of *cirA* mRNA for control by OmrA/B
----------------------------------------------------------

Many targets of sRNAs have relatively long 5′ untranslated regions (UTRs) that participate in the regulation, for instance by adopting a structure that can promote the interaction with the regulatory sRNA ([@B34]). At first sight, *cirA* could fall into the category of these targets, since it carries a long UTR. Indeed, two promoters of *cirA* have been identified: p1, leading to transcription of a 173-nt untranslated leader, and p2, leading to transcription of a 160-nt untranslated leader ([@B35]). Both are present in the *cirA-lacZ* translational fusion used in this study. Two deletions were constructed to examine the role of this UTR in regulation by OmrA and OmrB. Deletion Δ1 extends from nts --149 to --54, deleting 96 nt; deletion Δ2 extends from nts --149 to --21, deleting 129 nt ([Figure 4](#F4){ref-type="fig"}A). Activity of the *cirAΔ1-lacZ* fusion was similar to the full-length fusion, and was subject to OmrA and OmrB-dependent repression ([Figure 4](#F4){ref-type="fig"}B). Although the degree of repression was less than that observed with the full-length leader, these results show that OmrA and OmrB do not require *cirA* sequences beyond those from --54 to +30 for regulation. Figure 4.Part of *cirA* leader is dispensable for post-transcriptional control by OmrA/B. Different mutations, depicted in (**A**), were introduced in the *cirA-lacZ* translational fusion. Their effect on the control by OmrA/B was then assayed by measuring the β-galactosidase activity of the resulting strains transformed with pBRplac vector or its derivatives expressing OmrA or OmrB. Nucleotides in red are conserved between OmrA and OmrB, and nucleotides in gray correspond to the start codon and the Shine--Dalgarno sequence of *cirA*. (**B**) The wt strain is MG1189, and strains MG1206, MG1205, MG1253, MG1255, MG1261 and MG1256 carry derivatives of the *cirA-lacZ* fusion with mutations Δ1, Δ2, mutI, mutIIa, mutI+IIa and mutIIb, respectively. Nucleotides shown as X are not conserved between OmrA and OmrB ([Figure 2](#F2){ref-type="fig"}). Figure 5.The 5′ end of OmrA/B interacts with the translation initiation region of *cirA* mRNA *in vivo*. Compensatory changes were introduced in both OmrA/B and/or the *cirA-lacZ* translational fusion (**A**). As in [Figure 4](#F4){ref-type="fig"}, their effect on the control was assayed by measuring the β-galactosidase activity of the resulting strains transformed with pBRplac or its derivatives (**B**). Mutant and wild-type forms of OmrA or OmrB accumulate at similar levels in the wild-type strain as shown by northern blot analysis (**C**). Strains used in this set of experiments are MG1189 (wt), MG1254 (*up*), MG1340 (*up/2*) and MG1341 (*up/3*).

The Δ2 deletion increased the basal activity (in the absence of OmrA and OmrB) by 1.75-fold, and control by OmrA and OmrB was almost fully abolished ([Figure 4](#F4){ref-type="fig"}B, Table S1), suggesting that at least some of the region between nts --54 to --21 of the *cirA* leader is crucial for OmrA/B action.

These results for the Δ1 and Δ2 fusions are consistent with the predicted pairing since Δ1 does not enter the predicted pairing region whereas Δ2 does ([Figure 4](#F4){ref-type="fig"}A). Several mutations were then introduced into the *cirA-lacZ* fusion to further examine whether pairing with the TIR of *cirA* is required for OmrA/B action.

In the predicted pairing ([Figure 4](#F4){ref-type="fig"}A), the longest stretch of continuous pairing, arbitrarily referred to as pairing region I, is an 8- or 9-nt region that extends from nts −35 to −28/−27 of *cirA*, pairing with a region that is not completely conserved between OmrA and OmrB. The second stretch of pairing involves 12 nt of OmrA and B, starting very close to the 5′ C of these sRNAs, and three regions of *cirA*, of 3 nt, 6 nt and 3 nt respectively, separated in each case by a single unpaired base ([Figure 4](#F4){ref-type="fig"}A). These pairing regions were arbitrarily referred to as IIa, IIb and IIc, respectively. Changes in region I or IIa of *cirA* that are expected to disrupt pairing in these regions (mutI and mutIIa respectively, [Figure 4](#F4){ref-type="fig"}A) did not disrupt regulation by OmrA/B ([Figure 4](#F4){ref-type="fig"}B, Table S1). In addition, combining these mutations (mutI+IIa) gave regulation very similar to that seen in the wt case ([Figure 4](#F4){ref-type="fig"}B). Therefore, pairing in regions I and IIa is not required for control by OmrA/B in our experimental conditions, which leaves only the pairing of 9 nt in regions IIb and IIc. Consistent with a crucial role for these regions, a mutation expected to disrupt the three last base-pairs of region IIb (mutIIb), almost fully abolished control by OmrA or OmrB ([Figure 4](#F4){ref-type="fig"}B, Table S1).

OmrA and OmrB base-pair with *cirA* mRNA *in vivo*
--------------------------------------------------

To directly test whether the predicted *cirA*-OmrA/B pairing in regions IIb and IIc was critical for regulation, effects of mutations and compensatory mutations in the sRNAs and the *cirA-lacZ* fusion were tested *in vivo*. Mutations in *cirA-lacZ* that changed blocks of 3--5 nt were made as shown in [Figure 5](#F5){ref-type="fig"}; the compensating mutations, indicated with a asterisk (\*), were constructed in both OmrA and OmrB and gave wt levels of RNA ([Figure 5](#F5){ref-type="fig"}C).

In the *cirA-lacZ* mutant referred to as mut2, the nine predicted base-pairs in regions IIb and IIc are disrupted by a 3-nt change ([Figure 5](#F5){ref-type="fig"}A). Probably because the first G of the *cirA* Shine--Dalgarno (SD) sequence is changed into a C with this mutation, the activity of the *cirAmut2-lacZ* fusion was extremely low (\<2 Miller units when transformed with the empty vector, data not shown). This rendered it virtually impossible to measure the effect of OmrA/B on the expression of this fusion. Therefore, we took advantage of an up-mutant that we constructed while in the process of characterizing the *cirA* untranslated region. This mutant, referred to as 'up', consists in a change of 4 out of the 6 nt between the SD sequence and the AUG start codon ([Figure 5](#F5){ref-type="fig"}A). The activity of the resulting *cirAup-lacZ* fusion is more than 8-fold higher than the activity of the wt fusion ([Figure 5](#F5){ref-type="fig"}B, compare scale on two panels). In addition, consistent with the fact that the 'up' change affects nucleotides that are not predicted to base-pair with the sRNAs, OmrA and OmrB were found to efficiently repress the activity of the *cirAup-lacZ* fusion ([Figure 5](#F5){ref-type="fig"}B, Table S1). Although the molecular mechanism underlying the increase in expression with the 'up' mutation is still unknown, we combined this change with other changes in the pairing region in order to study the effects of compensatory mutations in OmrA/B.

Two sets of mutations in the 5′ end of OmrA or OmrB were tested. Mutating positions 3--6 of the 5′ end of OmrA/B to create mut2\* ([Figure 5](#F5){ref-type="fig"}A) drastically reduced the ability of the Omr mutant RNAs to regulate the *cirAup-lacZ* fusion ([Figure 5](#F5){ref-type="fig"}B, right panel), consistent with required pairing of the 5′ end of OmrA and OmrB. Mutating the 5 nt between positions 6 and 10 ([Figure 5](#F5){ref-type="fig"}A, mut3\*) also greatly reduced regulation of the 'up' fusion. Both sets of mutations also reduced regulation of the wt fusion ([Figure 5](#F5){ref-type="fig"}B, left panel), consistent with the 'up' mutation not changing the basic-pairing properties of the *cirA-lacZ* fusion. Complementary mutations in the pairing regions of *cirA* were tested, in the context of the 'up' version of the *cirA-lacZ* fusion. While the up/2 double mutant had relatively low expression in the absence of the sRNAs, there was very little effect of expression of wt OmrA or OmrB (1.5- and 1.3-fold decrease, respectively). In contrast, OmrAmut2\* and OmrBmut2\* repressed the expression of the *cirAup/2-lacZ* fusion significantly (repression factors are 3.1 and 2.7 for OmrAmut2\* and OmrBmut2\*, respectively), supporting the predicted base pairing ([Figure 5](#F5){ref-type="fig"}B, Table S1).

This was further confirmed by using the mut3/mut3\* set of mutants. As previously, mut3 was combined with the *up* change in *cirA-lacZ* and the effect of OmrA/B was analyzed on the resulting *cirAup/3-lacZ* fusion as well as on the *cirAup-lacZ*. Wt OmrA and OmrB repressed the expression of the up fusion much better than the up/3 fusion; repression of 27.9-fold for OmrA regulation of the 'up' fusion was reduced to 2.3-fold for the up/3 fusion; for OmrB, repression of the up fusion was 11.5-fold and was reduced to 1.4 for the up/3 fusion ([Figure 5](#F5){ref-type="fig"}B, right panel). When the mut3\* compensating changes were present in the Omr sRNAs, regulation of the up/3 fusion was restored: OmrA/Bmut3\* repressed the up fusion poorly (about 1.5 fold) but the up/3 fusion well (about 6-fold) ([Figure 5](#F5){ref-type="fig"}B, Table S1).

All together, data presented in [Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"} clearly show that the 5′ terminal region of OmrA/B interacts *in vivo* with the TIR of *cirA* mRNA and that a relatively short pairing region of no more than 9 nt is sufficient for the regulation, at least when OmrA/B are overexpressed. It is worth noting that none of these mutations fully abolished regulation under these growth conditions, suggesting that the remaining even shorter pairing can provide some modest degree of regulation.

OmrA and OmrB base-pair with *ompT* mRNA *in vivo*
--------------------------------------------------

As for *cirA*, the importance of RNase E and Hfq in the control of *ompT* expression (see above) suggested a base-pairing with OmrA/B and such a base-pairing can be predicted in the vicinity of the *ompT* TIR ([Figure 6](#F6){ref-type="fig"}A). Interestingly, the region of OmrA/B that base-pairs with *cirA* (i.e. nts 2 to 10 of the sRNAs) is also predicted to be involved in the interaction with *ompT*, since nts 1 to 33 of OmrA or 1 to 32 of OmrB are expected to form an imperfect duplex with nts --15/--14 to +20 of *ompT* mRNA. Surprisingly, most of the region of *ompT* mRNA involved in this base-pairing is part of the coding sequence rather than of the 5′ UTR. Figure 6.The 5\' end of OmrA/B base-pairs with *ompT* mRNA *in vivo*. (**A**) Compensatory changes depicted in (A) were introduced in OmrA/B, *ompT* and *ompT-Flag* RNAs. Nucleotides in red are conserved between OmrA and OmrB and the ones in gray correspond to the *ompT* start codon and Shine--Dalgarno sequence. (**B**) Control was assayed by analyzing the accumulation of OmpT-Flag (strain MG1307) and OmpTmut2-Flag (strain MG1309) proteins when wild-type or mut2\* OmrA/B are overexpressed (**C**) Levels of *ompT* (strain MG1099), *ompTmut2* (strain MG1281) mRNAs as well as of their Flagged derivatives (strains MG1307 and MG1309, respectively) were monitored by northern blot before and after a 10-min induction of the different forms of OmrA/B sRNAs. SsrA and *ompA* RNAs were used as loading controls.

In order to determine whether this interaction occurs *in vivo*, the effect on the control of *ompT* expression of mutations in the longest stretch of predicted base pairs (the 9 bp between nts 1 and 9 of OmrA/B and nts 12 to 20 of *ompT* mRNA) was analyzed. Mutants in OmrA/B used in this set of experiments are OmrA/Bmut2\*, also used previously, while the mutant in *ompT* mRNA, referred to as *ompTmut2*, consists of the compensatory change ([Figure 6](#F6){ref-type="fig"}A).

Results obtained using these compensatory mutations and the previously described *ompT-lacZ* translational fusion as a reporter for *ompT* expression support the pairing between the 5′ end of OmrA/B and the early coding region of *ompT* mRNA (Table S1). However, given the very modest effect seen with the *ompT-lacZ* reporter, a number of other approaches were used to examine the importance of the predicted base-pairing. In both of the approaches discussed below, a full-length *ompT* gene is present and therefore, if sequences downstream of the *ompT-lacZ* fusion joint are critical for regulation, these should be present.

An *ompT-Flag* allele was used to further confirm this direct interaction *in vivo*. In this OmpT-Flag construct, an eight-amino-acid Flag tag (sequence DYKDDDDK) was introduced between amino acids S110 and N111 of OmpT (the numbering refers to the full-length protein, i.e. including the signal sequence). Based on the structure of OmpT ([@B36]), the Flag tag is expected to be in the second extracellular loop. As shown by western analysis using an anti-Flag antibody, the amount of OmpT-Flag clearly decreases in the presence of the plasmids overproducing OmrA or OmrB compared to the empty vector, but the mut2\* forms of OmrA/B are less effective ([Figure 6](#F6){ref-type="fig"}B, lanes 1--5). In this regard, this OmpT-Flag is a better reporter than the OmpT-β-galactosidase fusion for the action of OmrA/B, consistent with the idea that regions outside of those present in the fusion may contribute to regulation. Consistent with the predicted pairing, OmrAmut2\* and OmrBmut2\*, but not the wt OmrA and OmrB, decreased the cellular level of the OmpTmut2-Flag protein ([Figure 6](#F6){ref-type="fig"}B, lanes 6--10) made from an *ompTmut2-Flag* allele where the compensatory mutation was introduced. This clearly shows that OmrA/B base-pair with *ompT* mRNA *in vivo* in the beginning of the coding region. Therefore, the first 10 nt of both OmrA and OmrB mediate their interaction with at least two direct targets, *ompT* and *cirA*.

Finally, the ability of OmrA/B or OmrA/Bmut2\* to induce the degradation of *ompT* or *ompTmut2* mRNAs, as well as their flagged derivatives, was investigated. As previously shown, wt OmrA and OmrB induce degradation of *ompT* mRNA as soon as 10 min after induction. Surprisingly however, the level of *ompT-Flag* or *ompTmut2-Flag* mRNAs were not affected by the induction of wt or mut2\* OmrA/B, respectively ([Figure 6](#F6){ref-type="fig"}C), even though the synthesis of the corresponding proteins are controlled by these sRNAs ([Figure 6](#F6){ref-type="fig"}B). This strongly suggests that mRNA degradation is not required for translational control of *ompT* by Omr sRNAs. Finally, *ompTmut2* message was not degraded after a 10-min induction of mut2\* forms of OmrA/B ([Figure 6](#F6){ref-type="fig"}C) and similar results were obtained after a 30-min induction of the sRNAs (data not shown). A 4-nt change in the *ompT* mRNA is thus sufficient to change its sensitivity to Omr-promoted degradation.

The 5′ end of OmrA/B is also involved in the regulation of other targets of these sRNAs
---------------------------------------------------------------------------------------

Results presented so far show the crucial role of the conserved 5′ end of OmrA/B in the base-pairing with *ompT* and *cirA* targets. Consistent with these results, mutants in the 5′ end of these sRNAs, OmrAmut2\* or OmrBmut2\*, failed to induce the decay of *ompT* and *cirA* mRNAs seen with the wt sRNAs ([Figures 6](#F6){ref-type="fig"}C and [7](#F7){ref-type="fig"}B). We have previously shown that OmrA and OmrB have other targets, including two additional genes for outer membrane proteins, *fecA* and *fepA*. The effect of the mut2\* mutation in OmrA/B on the mRNA level of these other targets was investigated as well. [Figure 7](#F7){ref-type="fig"}B clearly shows that, as for *ompT* and *cirA*, mRNA levels of *fecA* and *fepA* are decreased after induction of the wt forms of OmrA/B (see also reference 20), but not after induction of their mut2\* counterparts. Therefore, the 5′ end of OmrA/B plays a major role in the regulation of at least four targets. In the case of *ompT* and *cirA*, this is due to a direct base-pairing between the target-mRNA and OmrA/B 5′ end. The same may be true for *fecA* and *fepA* as well, but we cannot exclude indirect regulation of these targets by OmrA/B, in which case the mut2\* mutation could affect the level of an intermediate regulator instead. Figure 7.The 5′ end of OmrA/B is involved in the regulation of multiple targets, including *ompR*. (**A**) Predicted base-pairing between *ompR* mRNA and OmrA/B. Nucleotides in red are conserved between OmrA and OmrB and the ones in gray correspond to the *ompR* start codon and Shine--Dalgarno sequence. (**B**) Northern blot analysis of target mRNA before and after induction of wt or mut2\* OmrA/B. SsrA and *ompA* RNAs were used as loading controls. OmrA, OmrB, SsrA, *ompT*, *ompR* and *ompA* RNAs were analyzed in the MG1099 strain, whereas the *fur^−^* strain MG1100 was used for *cirA*, *fecA* and *fepA* mRNAs. Induction of OmrA/B as well as the levels of SsrA and *ompA* mRNA were as expected in MG1100 (data not shown). (**C**) Effect of compensatory changes in *ompR-lacZ* mRNA and/or OmrA/B sRNAs on the activity of a pBAD-*ompR-lacZ* translational fusion. Fusion strains are MG1398 (wt) and MG1403 (mut2).

Both OmrA and OmrB directly regulate the expression of their transcriptional activator, *ompR*
----------------------------------------------------------------------------------------------

Given these results, we used the program TargetRNA ([@B37]) to search for potential pairing between the first 10 nt of OmrA/B and the TIR of *E. coli* mRNAs, with the idea that additional potential targets might be found. The search was done using the following criteria: focus around nts --30 to +20 of mRNA relative to the start codon, a hybridization seed of 6 bp allowing G:U base-pairs, and a *P*-value threshold of 0.3. With these fairly permissive criteria, *ompT* was ranked 5 (*P*-value = 0.0338288) and *cirA* was ranked 48 (*P*-value = 0.137068), whereas *fecA* and *fepA* were not present among the first 100 predicted targets. Interestingly, the first predicted target is *yjcH* (*P*-value = 0.00800168), and mRNA levels for both genes of the *yjcH-yjcG* operon were strongly decreased after induction of OmrA or OmrB in microarrays experiments ([@B20]). Similarly, ranked at the eighth position with a *P*-value of 0.0338288 is *ompR*, encoding the transcriptional regulator of several genes including *omrA* and *omrB*. *ompR* is the first gene of the *ompR-envZ* bicistronic operon and both *ompR* and *envZ* mRNA levels were found to be reproducibly decreased by 2-fold after OmrA or OmrB induction in *E. coli* ([@B20]). The same was true for *ompR* in *Salmonella* (Papenfort,K. and Vogel,J., personal communication). Altogether, these results suggest that OmrA/B could base-pair with the leader of *yjcH* or *ompR* and thereby regulate the expression of the corresponding operons. Besides *ompT*, *yjcH* and *ompR*, the other genes among the 10 first predicted targets were either poorly expressed or their expression was unchanged in the presence or absence of OmrA or B as assayed by microarray experiments ([@B20]).

The possibility that *ompR* could be a direct target of OmrA/B was further reinforced when we investigated the effect of ectopically overproducing wt and mut2\* OmrA/B on *ompR* mRNA levels by northern blot. When we used a 42-nt probe complementary to nts 98 to 137 of *ompR* mRNA, two distinct mRNA species were detected ([Figure 7](#F7){ref-type="fig"}B). The larger band migrates between 2.0 and 2.5 kb (data not shown), which is consistent with the size of the *ompR-envZ* bicistronic mRNA. The smaller band migrates above 1.0 kb and could correspond to an alternative transcription product, a processing product or could be due to a nonspecific hybridization, but this was not investigated further. As shown in [Figure 7](#F7){ref-type="fig"}B, induction of wt OmrA or OmrB, but not of OmrAmut2\* or OmrBmut2\*, decreased the level of *ompR-envZ* mRNA, while the amount of the smaller transcript was not affected. This result shows that OmrA/B negatively controls the expression of the *ompR-envZ* operon, and that, as for other targets of these sRNAs, the 5′ end of OmrA/B is involved in this control.

Given these results, it seems likely that the predicted pairing mentioned above between the *ompR* 5′ UTR and OmrA/B (shown in [Figure 7](#F7){ref-type="fig"}A) exists *in vivo*. In order to test this, a translational *ompR-lacZ* fusion was constructed. Transcription of this fusion is driven by the P~BAD~ promoter and the transcription start site is expected to be the same as that for the *ompR* promoter p1 ([@B38]). The 5′ UTR should therefore be 123-nt long. *lacZ* is fused in frame after the 30th nucleotide of the *ompR* coding region (i.e. after the 10th amino acid). The activity of the resulting fusion was decreased by 3- or 2.5-fold, respectively when OmrA or OmrB was ectopically overexpressed ([Figure 7](#F7){ref-type="fig"}C, Table S1), showing that the region between nts --123 and +30 of *ompR* mRNA is sufficient for some control by OmrA/B. Mutants in the 5′ end of OmrA/B such as OmrA/Bmut2\* were unable to control the expression of this fusion. However, OmrA/Bmut2\* downregulated by 4.2-fold the expression of an *ompRmut2-lacZ* fusion bearing the compensatory changes; wt OmrA/B had no effect on this fusion ([Figure 7](#F7){ref-type="fig"}C, Table S1). These data show that OmrA/B post-transcriptionally regulate the expression of *ompR* by base-pairing with its 5′ UTR *in vivo*.

DISCUSSION
==========

OmrA and OmrB, two adjacent and partially homologous Hfq-binding sRNAs, are positively regulated by the EnvZ/OmpR two-component system and negatively regulate a set of outer membrane proteins. Here, we have examined the nature of the interaction of OmrA and OmrB with their targets. As for other Hfq-binding RNAs, we find that the action of OmrA/B depends on Hfq and on RNase E. We also find that the conserved 5′ end of OmrA and OmrB is required for interaction with and/or regulation of all of the tested targets. Interestingly, a similar pattern of interaction has recently been observed for RybB sRNA ([@B39]; Mika,F. and Vogel,J., in preparation). Finally, we find that one direct target of OmrA and OmrB is the mRNA encoding the transcriptional regulators of these sRNAs, EnvZ and OmpR, thus providing a feedback loop in which activation of transcription will downregulate expression of the activators.

Common pairing interactions with OmrA and OmrB for multiple targets
-------------------------------------------------------------------

We found that interaction between the 5′ end of OmrA/B and nts --10 to --19 of *cirA* mRNA is sufficient for the control of *cirA*. This pairing region in *cirA* is conserved in other enterobacteria where OmrA/B are found, such as *Salmonella*, *Yersinia* and *Klebsiella* species (Figure S1), suggesting that *cirA* expression is subject to post-transcriptional control by OmrA/B in these species as well. Pairing with *cirA* seems to follow the general scheme of negatively acting sRNAs: it involves the SD sequence and most likely regulates *cirA* expression by competing with ribosome binding. Consistent with that, the activity of a translational *cirA-lacZ* fusion carrying the region of pairing was strongly decreased upon overexpression of OmrA/B.

The 5′ end of *E. coli* OmrA/B also base-paired with nts 12 to 20 of *ompT* ORF. Even though this pairing occurs downstream of the RBS, it is probably close enough to inhibit ribosome binding. Indeed, the interaction between *Salmonella* RybB sRNA and the early coding sequence of *ompN* (downstream of the AUG) is sufficient to inhibit translation initiation of this target ([@B39]). The *ompT* gene is part of the cryptic lambdoid DLP12 prophage and no close homolog of this gene was found in *Klebsiella pneumoniae* or *Salmonella* genomes ([@B40]). Nevertheless, members of the family of outer membrane proteases defined by OmpT, the Omptin family, are encoded by *Yersinia* (*pla* gene) or *Salmonella* (*pgtE* gene), but the OmrA/B-*ompT* pairing is not conserved with these genes (Figure S1). Therefore, the synthesis of *Yersinia* Pla and *Salmonella* PgtE may not be directly controlled by OmrA/B, even though we cannot exclude an unidentified alternative pairing in these cases.

Pairing with the same 5′ region of OmrA and OmrB is also required for regulation of *envZ/ompR*; in this case, pairing is again upstream of the AUG and partially overlapping the RBS. As for *cirA*, this pairing is conserved in other enterobacteria (Figure S1). Finally, the same 4-nt mutation (mut2\*) that disrupts pairing with *ompR*, *ompT*, and *cirA* also abolishes regulation of *fepA* and *fecA*, suggesting that all OmrA and OmrB targets depend on this 5′ region.

Pairing of the same region of an sRNA to multiple targets may be a general rule; for instance, a conserved region of GcvB sRNA is involved in its interaction with as many as seven different targets ([@B41]). In the case of OmrA/B, the participation of the 5′ end of the sRNA may provide increased flexibility or allow easier accessibility to mRNAs. Pairing to multiple targets through the 5′ end of a sRNA has also been observed with *Salmonella* RybB sRNA, that interacts with several OMP-encoding mRNAs (Mika,F. *et al.*, submitted). Interestingly, MicC and MicF, that respectively inhibit synthesis of OmpC and OmpF porins, also paired with the corresponding target-mRNAs through their 5′ end ([@B42],[@B43]). This is reminiscent of the 5′ end seed used for pairing by eukaryotic miRNAs ([@B44]).

The conservation of this 5′ end region between OmrA and OmrB is consistent with the fact that both sRNAs can regulate all targets identified so far. Such redundancy in regulation of shared targets is not unusual for duplicated sRNAs ([@B45],[@B46]), but does raise the question of why these small RNAs are duplicated in some species, but not others such as *Yersinia pestis*. It is also worth noting that, in addition to conservation of the 5′ end (which extends well beyond the pairing region, to nt 21), the last 35 nt of OmrA/B are conserved as well. Although some of these 3′ end nts are part of the transcriptional terminator, this conservation pattern may suggest that additional targets of OmrA/B remain to be identified that pair with the 3′ conserved regions, or that this region plays other roles in sRNA function.

Other components of *cirA* regulation
-------------------------------------

*cirA* mRNA has a rather long leader \[173- or 160-nt long if transcription is driven by p1 or p2, respectively ([@B31])\]. Even though pairing of OmrA/B with nts --10 to --19 of *cirA* leader is sufficient for the control in our experimental conditions, we found that deleting nts --20 to --149 (i.e. outside of the sufficient pairing region) almost fully abolished this regulation ([Figure 4](#F4){ref-type="fig"}, deletion Δ2). Some of the leader may therefore ensure an optimal conformation for the pairing region to interact with the sRNAs.

On the other hand, it is clear that most of this leader is not necessary for control by OmrA/B, given that a deletion of nts --54 to --149 of the leader still gives good regulation ([Figure 4](#F4){ref-type="fig"}, deletion Δ1). It is therefore conceivable that, in addition to the effects of OmrA/B, other post-transcriptional controls regulate the expression of *cirA* via this leader region.

Yet another level of control is suggested by the surprising effect of the 'up' mutation ([Figure 5](#F5){ref-type="fig"}): changing 4 out of the 6 nt between the SD sequence and the start codon of *cirA* increased the activity of the *cirA-lacZ* fusion by more than 8-fold. Preliminary data indicate that changing either the G or A just upstream of the AUG into an U is sufficient to increase the expression of *cirA-lacZ* by about 3-fold (our unpublished data). It seems therefore that the increase in expression could be due to the disruption of the GGAA sequence between nts --3 and +1, which resembles an SD sequence and may be used to initiate translation from an alternative start codon. Interestingly, this GGAA sequence is conserved in *Salmonella* and *Klebsiella*, and, in *Yersinia*, there is an AGAG sequence instead, that could also be considered as a potential SD sequence (Figure S1). Whether this model is true and whether it is a process regulating, rather than simply decreasing, *cirA* expression remains to be investigated.

Complexity of *ompT* regulation and mRNA turnover
-------------------------------------------------

*ompT* regulation by OmrA and OmrB is easily demonstrated at the mRNA level for the wt *ompT* message; mRNA disappears rapidly upon induction of the sRNA ([Figures 1](#F1){ref-type="fig"}, [3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}). However, in experiments done with an *ompT*-*lacZ* fusion carrying the 5′ UTR and the first 30 nt of *ompT*, regulation by OmrA/B overproduction is poor ([Figure 3](#F3){ref-type="fig"}A). Since this suggested the possibility that elements beyond nt +30 were required, control was analyzed using the chromosomal copy of *ompT*, either in its wt or Flag-tagged form. In contrast to the *ompT-lacZ* fusion, *ompT* mRNA downstream of nt +30 is present in these constructs, but may be modified by the insertion of the 24-nt Flag sequence. The accumulation of the Flagged proteins is clearly controlled by OmrA/B, both in the wt situation as well as when compensatory changes were introduced in *ompT-flag* mRNA and in OmrA/B ([Figure 6](#F6){ref-type="fig"}B). However, compensatory changes did not restore the ability of OmrA/B to induce the degradation of *ompTmut2* mRNA or *ompTmut2-Flag* mRNA ([Figure 6](#F6){ref-type="fig"}C). In general, degradation of the *ompT* mRNA in response to the Omr RNAs was perturbed by every change we made. For instance, the *ompT-Flag* mRNA (not carrying a mutation) is poorly sensitive to degradation by wt sRNAs ([Figure 6](#F6){ref-type="fig"}C).

The mut2 mutation, in which the fifth and sixth codons of *ompT* are changed from CUUCUG (Leu-Leu) to CUGUUC (Leu-Phe), also decreases the level of OmpT-Flag protein ([Figure 6](#F6){ref-type="fig"}B, compare the two vector lanes). This is independent of OmrA/B, since the experiment was done in a *ΔomrAB* strain. This sequence is part of the signal sequence and it is possible that the mutation affects the efficiency of export of the resulting protein to the outer membrane. Thus, it seems likely that mRNA structure, stability, and translation efficiency are perturbed by the addition of a Flag tag and by the mut2 change, hinting at further complexity in the regulation of *ompT*.

It was shown previously that the control of the IICB^Glc^ inner membrane protein synthesis by SgrS sRNA required the membrane localization of the target-mRNA, presumably because this decreased ribosome loading on the mRNA, allowing the sRNA to successfully compete with the ribosome ([@B47]). Even though the localization process is somewhat different for outer membrane proteins such as OmpT, one can hypothesize that, in a similar way, the translation of *ompT* may be affected by sequences within the signal sequence in ways that perturb OmrA/B action. This could explain, at least in part, why OmrA/B only weakly decreases the expression of the *ompT-lacZ* fusion.

Autoregulation by OmrA and OmrB
-------------------------------

The expression of several sRNAs is subject to feedback control. For instance, RybB sRNA, whose transcription is regulated by the alternative sigma factor sigmaE, indirectly downregulates the expression of sigmaE by decreasing the synthesis of several OMPs ([@B48],[@B49]). Similarly, production of the Fur-regulated RyhB sRNA represses the synthesis of iron-binding proteins, thereby increasing the cellular level of free iron, which will in turn repress the expression of the Fur regulon, which includes RyhB itself ([@B50]). Another example comes from *Vibrio cholerae*, where the four redundant Qrr sRNAs inhibit expression of the HapR regulator, which indirectly represses synthesis of the Qrr ([@B51]). In our case, OmrA/B sRNAs negatively autoregulate their transcription by directly repressing the *ompR-envZ* operon that encodes their transcriptional activators. This feedback loop should limit the production of OmrA/B after induction of the EnvZ-OmpR two-component system. However, it was found that there was almost no change in the transcription of two members of the EnvZ-OmpR regulon, *ompC* and *ompF*, over a wide range of EnvZ and OmpR levels ([@B52]), and the physiological relevance of OmrA/B autoregulation remains therefore to be investigated.

Length of pairing regions
-------------------------

Our results show that relatively short regions of complementarity between OmrA/B and their targets are sufficient for translational control by these sRNAs in our experimental conditions. It is especially striking for *cirA*, where mutagenesis of the leader indicates that two stretches of 6 and 3 bp with the sRNA are sufficient for control. sRNA--mRNA interactions relying on very short regions of complementarity are not limited to the Omr sRNAs, since Aiba and co-workers ([@B33]) showed that, when mutagenizing the duplex between SgrS sRNA and *ptsG* mRNA, only 6 bp affected control when point mutants were introduced. One drawback of both our and Aiba\'s group results is that the effect of mutations in either the sRNA or the target-mRNA was analyzed under conditions where the sRNA was overproduced, which could compensate for weaker interactions. Therefore, we cannot exclude that additional base-pairs contribute to the interaction with the targets when sRNAs are expressed at lower levels from the chromosome. In the future, it might be worthwhile to undertake the same kind of study after inducing the sRNA synthesis under conditions that would be closer to the physiological levels. It would also be interesting to determine whether having the pairing region at the very 5′ end of OmrA/B allows control through shorter base-pairing interactions.
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